Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MSD Malaysia is the local subsidiary of Merck & Co., a global research-driven pharmaceutical leader dedicated to discovering and delivering innovative health solutions. Established in 1997, the company provides a broad portfolio of prescription medicines, vaccines, and animal health products to the Malaysian market. Its primary focus areas include oncology, infectious diseases, diabetes, and vaccines, with flagship products such as Keytruda and Gardasil. MSD Malaysia actively collaborates with local healthcare providers and government agencies to improve patient access and advance clinical research within the country.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MSC Malaysia.